CAV1 and hepatocellular carcinoma: Our study suggested that CP administration induced autophagic degradation of Cav-1, subsequently activated the Akt/GSK3β-mediated proteasome degradation of β-catenin via ubiquitination activation, and resulted in suppressing metastasis-promoting effect of Cav-1 in HBV-associated HCC.